CS252629B1 - Biologically active halogen-containing 2H-benzopyran derivatives per molecule and method for their preparation - Google Patents
Biologically active halogen-containing 2H-benzopyran derivatives per molecule and method for their preparation Download PDFInfo
- Publication number
- CS252629B1 CS252629B1 CS862875A CS287586A CS252629B1 CS 252629 B1 CS252629 B1 CS 252629B1 CS 862875 A CS862875 A CS 862875A CS 287586 A CS287586 A CS 287586A CS 252629 B1 CS252629 B1 CS 252629B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- carbon atoms
- group
- maximum
- halogen
- benzopyran
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Podstatou řešení jsou deriváty 2H-benzopyranu obsahující halogen v molekule obecnéi kde R1 až R3 značí nezávisle na sobě alkylskupinu s maximálně 3 atomy uhlíku, fenylskupinu, fenylskupinu substituovanou hydroxyskupinou nebo alkykarbonyloxyskupinou s maximálně 4 atbnty uhlíku v alkylu, nebo 7 9 4 5 R a R tvoří spolu skupinu =0, R a R značí halogen nebo alkoxyskupinu s maximálně 6 atomy uhlíku takovým způsobem, že značí-li R4 halogen, R5 značí alkoxyskupinu a naopak. Způsob přípravy derivátů 2H-benzopyranu obsahujících halogen obecného vzorce I spočívá v reakci 2H-benzopyranového derivátu obecného kde symboly R1 až R3 mají výše uvedený význam, s alkanolem s maximálně 6 atomy uhlíku v alkylu a N-halogensukcinimidem při teplotě 0 až 5 °C.The essence of the solution is 2H-benzopyran derivatives containing halogen in the molecule of general formula I where R1 to R3 independently denote an alkyl group with a maximum of 3 carbon atoms, a phenyl group, a phenyl group substituted by a hydroxy group or an alkylcarbonyloxy group with a maximum of 4 carbon atoms in the alkyl, or 7 9 4 5 R and R together form a group =0, R and R denote a halogen or an alkoxy group with a maximum of 6 carbon atoms in such a way that if R4 denotes halogen, R5 denotes an alkoxy group and vice versa. The method of preparing 2H-benzopyran derivatives containing halogen of general formula I consists in the reaction of a 2H-benzopyran derivative of general formula I where the symbols R1 to R3 have the above-mentioned meaning, with an alkanol with a maximum of 6 carbon atoms in the alkyl and N-halosuccinimide at a temperature of 0 to 5 °C.
Description
Vynález se týká derivátů 2H-benzopyranu obsahujících halogen v molekule a způsobu jejich přípravy, které se jeví jako biologicky účinné látky.The invention relates to halogen-containing 2H-benzopyran derivatives in a molecule and to a process for their preparation which appears to be biologically active substances.
Sloučeniny, jež jsou předmětem přihlášky vynálezu, způsobují ve svém výsledném účinku u hmyzu vývojovou deviaci.The compounds of the present invention cause developmental deviation in insect effect.
Podstatou předmětného vynálezu jsou deriváty 2H-benzopyranu obsahující halogen v molekule obecného vzorce I .The present invention provides halogen-containing 2H-benzopyran derivatives of the formula I.
kdewhere
33
R až R značí nezávisle na sobě alkylskupinu s maximálně 3 atomy uhlíku, fenylskupinu skupinu substituovanou hydroxyskupinou nebo alkylkarbonyloxyskupinouR @ 1 to R @ 2 are, independently of one another, an alkyl group having a maximum of 3 carbon atoms, a phenyl group substituted with a hydroxy group or an alkylcarbonyloxy group
3 * s maximálně 4 atomy uhlíku v alkylu nebo R a R tvoří spolu skupinu =0,3 * with up to 4 carbon atoms in alkyl or R and R together form = O,
R4 a r5 značí halogen nebo alkoxyskupinu s maximálně 6 atomy uhlíku takovým způ4 5 sobem, že značí-11 R halogen, R značí alkoxyskupinu a naopak.R 4 and R 5 denote halogen or an alkoxy group having a maximum of 6 carbon atoms in such a way that R 11 denotes halogen, R denotes alkoxy and vice versa.
Způsob přípravy derivátů 2H-benzopyranu obsahujících halogen v molekule se vyznačuje tím, že se 2H-benzopyranový derivát obecného vzorce IIProcess for preparing halogen-containing 2H-benzopyran derivatives in a molecule is characterized in that the 2H-benzopyran derivative of the general formula II
kde symboly r! až R^ mají výše uvedený význam nechá reagovat s alkanolem s maximálně 6 atomy uhlíku v alkylu a N-halogensukcinimidem při teplotě 0 až 5 °C.where symbols r! to R ^ as defined above is reacted with an alkanol having a maximum of 6 carbon atoms in the alkyl and N-halosuccinimide at a temperature of 0 to 5 ° C.
V dalším je vynález blíže objasněn na příkladu provedení, aniž se na tento výlučně omezuje.In the following, the invention is explained in more detail by way of example without being limited thereto.
PříkladExample
K roztoku 0,32 g (0,0015 mol) 2,2-dimetyl-6-propionyl-2H-benzopyranu v 5 ml bezvodého metanolu bylo v atmosféře suchého dusíku přidáno při teplotě 0 až 5 °C 0,53 g (0,003 mol) N-bromsukcinimidu. Reakční směs byla míchána při této teplotě ještě 15 minut a poté byla zředěna vodou a extrahována dietyléterem. Ěterická vrstva byla vysušena nad bezvodým síranem hořečnatým a za sníženého tlaku odpařena. Zbytek byl chromatografován na silikagelu s 8 hmot. í vody (eluční činidlo petroléter obsahující až 20 obj. % dietyléteru).To a solution of 0.32 g (0.0015 mol) of 2,2-dimethyl-6-propionyl-2H-benzopyran in 5 ml of anhydrous methanol was added 0.53 g (0.003 mol) at 0-5 ° C under a dry nitrogen atmosphere. N-bromosuccinimide. The reaction mixture was stirred at this temperature for 15 minutes and then diluted with water and extracted with diethyl ether. The ethereal layer was dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was chromatographed on silica gel with 8 wt. % water (eluent petroleum ether containing up to 20 vol% diethyl ether).
Chromatografie poskytla 0,3 g (61 %) 2,2-dimetyl-3-brom-3,4-dihydro-4-metoxy-6-propionyl -2H-benzopyranu. IC analýza (CC14, 3%) : 2823 (VC-H v OCH-j), 1686 (V C=O), 1607, 1591, 1491 (V arom.), 1460 (5 asCH3 v OCH3) , 1386, 1371 (ó'sCH3) cm-1.Chromatography gave 0.3 g (61%) of 2,2-dimethyl-3-bromo-3,4-dihydro-4-methoxy-6-propionyl-2H-benzopyran. IC analysis (CCl 4 , 3%): 2823 (VC-H in OCH-j), 1686 (VC = O), 1607, 1591, 1491 (V arom.), 1460 (5 and CH 3 in OCH 3 ), 1386, 1371 (δ ' s CH 3 ) cm -1 .
MS analýza: 326/8 /C15H19BrO3), 311/3 (C14HlgBrO3) , 297/9 (C13H14BrC>3), 265/7 (C12H10BrO2), 247 (C15H19O3), 231 (C14H15O3> , 215 (C14H15O2> , 201 <C13HnO2) , 193 (CnH13O3) ,MS analysis: 326/8 / C 15 H 19 BrO 3) 311/3 (C g H 14 BrO 3) 297/9 (C 13 H 14 BRC> 3) 265/7 (C 12 H 10 BrO 2 ), 247 (C 15 H 19 O 3 ), 231 (C 14 H 15 O 3 >, 215 (C 14 H 15 O 2 >, 201 <C 13 H n O 2 ), 193 (C n H 13 O 3) )
192 (C11H12O3), 185 (C12HlgO2) , 163 (Cg^Og) , 73 (C^gO) , 57 (C^O) .192 (C 11 H 12 O 3), 185 (C 12 H g O 2), 163 (C ^ Og), 73 (C ^ MgO), 57 (C = O).
NMR analýza (CDClj/TMS), δ (ppm): 1,2 t(3H) CH3CH2CO, 1,49 s(3H), 1,60 s(3H) (CHjtjC, 2,95 q(2H) CH3CH;, 3,57 s(3H) OCHj, 4,3 d(H), 4,7 d(H) CH,6,86-7,92 m(3H) ArH.NMR analysis (CDCl 3 / TMS), δ (ppm): 1.2 t (3H) CH 3 CH 2 CO, 1.49 s (3H), 1.60 s (3H) (CH 3 Cl 2 , 2.95 q (2H) ) CH 3 CH, 3.57 s (3H) OCH, 4.3 d (H), 4.7 d (H) CH, 6.86 to 7.92 m (3H) Ar.
Stejným způsobem byl připravenIn the same way he was ready
2.2- dimetyl-3-metoxy-3,4-dihydro-4-brom-6-[dimetyl-(4-acetoxyfenyl)]-metyl-2H-benzopyran; iC analýza (CC143%): 2827 (v CH3 v OCH3), 1767, 1753 (v C=O), 1613, 1588, 1507,2,2-dimethyl-3-methoxy-3,4-dihydro-4-bromo-6- [dimethyl- (4-acetoxyphenyl)] - methyl-2H-benzopyran; iC analysis (CCl 4 3%): 2827 (in CH 3 in OCH 3 ), 1767, 1753 (in C = O), 1613, 1588, 1507,
1496 (v arom.), 1467 (δ CH, v OCH,), 1370, 1385 δ„ CH,) cm1. MS analýza: 446/8 as j a S j (C23H27BrO4), 431/3 (C22H24BrO4), 404/6 (C21H25BrO3), 389/91 (C^I^BrOj), 346/8 (C1?H15BrO3) 331/3 (ClgH12BrO3) , 321 (C^HjjOj) , 313 (C^H^Oj), 255 (Cj^gOj), 135 (CgH^) , 73 (C^O) . NMR analýza (CDClj/TMS): 1,44 s,l,56s(6H) (CH3)2C-O, l,65s(6H) <Cg3)2C-arom., 2,27s(3H) CHjCOO, 3,43s(3H) OCg3, 4,29d(H), CH-OCHj, 4,67d(H), CHBr, J=7,6, 6,69d(Η)arom.kondens. s heteroxyklem, J=8,6, 6,90-7,05m(3H) arom.kondens. s heterocyklem, 2H arom., 7,05-7,25m(3H) arom.kondens. s heterocyklem,2H arom.1496 (in arom.), 1467 (δ CH, in OCH,), 1370, 1385 δ „CH,) cm 1 . MS analysis: 446/8 as I S j (C 23 H 27 BrO 4) 431/3 (C 22 H 24 BrO 4) 404/6 (C 21 H 25 BrO 3), 389/91 (C-I ^ militates) 346/8 (C 1? H 15 BrO 3) 331/3 (C g H 12 BrO 3), 321 (C-HjjOj), 313 (C ^ H ^ Oj), 255 (C-goy) 135 (C 8 H 6), 73 (C 6 H 6). NMR analysis (CDCl 3 / TMS): 1.44 s, 1.56s (6H) (CH 3 ) 2 CO, 1.65s (6H) (C 3 ) 2 C-arom., 2.27s (3H) CH 3 COO, 3.43s (3H) OCg 3 , 4.29d (H), CH-OCH 3, 4.67d (H), CHBr, J = 7.6, 6.69d (Η) arom. with heteroxy, J = 8.6, 6.90-7.05m (3H) aromatic condens. with heterocycle, 2H arom., 7.05-7.25m (3H) aromatic condens. with heterocycle, 2H arom.
a 2,2-dimetyl-3-metoxy-3,4-dihydro-4-brom-6-[dimetyl-(4-hydroxyfenyl)] metyl-2H-benzopyran;and 2,2-dimethyl-3-methoxy-3,4-dihydro-4-bromo-6- [dimethyl- (4-hydroxyphenyl)] methyl-2H-benzopyran;
IC analýza (CC14,3%): 3609,3527(vOH), 2827 (vCH3 v OCHj), 1767, 1722 (v C=O), 1613, 1588, 1507, 1496 (v arom.), 1385, 1370 (6gCH3> cm1. MS analýza: 404/6 (C^H^BrOj) , 389/91 (C2QH22BrO3) , 372/4 (C2()H21BrO2) , 357/9 (C19H18BrO2> , 342/4 (ClgH15BrO2), 294 IC^HjgOj) ,IC analysis (CCl 4 , 3%): 3609.3527 (vOH), 2827 (vCH 3 in OCH 3 ), 1767, 1722 (in C = O), 1613, 1588, 1507, 1496 (in arom.), 1385, 1370 (6 g CH 3> cm first MS analysis: 404/6 (C ^ H ^ militates) 389/91 (C 2Q H 22 BrO 3) 372/4 (C 2 () H 21 BrO 2) 357/9 (C 19 H 18 BrO 2> 342/4 (C g H 15 BrO 2) 294 IC HjgOj)
279 (C18H15O3), 264 (C1?H12O3) , 263 (C^H^Oj) , 149/51 (^HgBrO) , 83 (C^O) .279 (C 18 H 15 O 3), 264 (C 1? H 12 O 3), 263 (C ^ H ^ Oj) 149/51 (^ HgBrO), 83 (C = O).
Biologické účinky byly sledovány:Biological effects were monitored:
u termitů: bylo zjištěno ovlivnění vývoje vojáků a bílých vojáků, ovlivnění zastoupení kast a z toho plynoucí nesoběstačnost a zánik kolonií, rovněž tak byla zjištěna celková retardace vývoje.for termites: it was found that the development of soldiers and white soldiers, the influence of castes and the resulting lack of self-sufficiency and colony destruction were found, as well as the overall development retardation.
Jako testovacího organismu bylo použito Prorhinotermes simplex (aplikace na chromatografický papír Whatman č. 1, v acetonu). V laboratorních koloniích testovacího hmyzu v době trvání pokusu, tj. cca 20 dnů je třeba pro úspěšné sledování antijuvenilního účinku nejprve vyvolat metoprénem nebo jiným silným juvenilizačním agensem efekt vysokého stupně determinace vývoje na vojenskou kastu. Antijuvenilní látky zabraňují účinku metoprénu nebo jinému silnému juvenilizačnímu agens, což vede v závislosti na poměru koncentrací obou látek v systému ke snížení počtu vojáků, případně je vzniku vojáků zcela zabráněno. V řadě případů vznikají přechodné formy mezi vojáky a larvami, tzv. interkasty. Ovlivněni je uváděno ve formě zlomku, kde v čitateli je uvedeno procento vzniklých plně vyvinutých bílých vojáků, zatímco ve jmenovateli se uvádí procento vzniklých interkastů.Prorhinotermes simplex (application to Whatman # 1 chromatography paper, in acetone) was used as the test organism. In laboratory colonies of test insects for the duration of the experiment, ie about 20 days, for the successful monitoring of the antijuvenile effect, the effect of a high degree of developmental determination on the military caste must first be induced by methoprene or other strong juvenilizing agent. Antijuvenile agents prevent the effect of metoprene or other strong juvenilizing agents, which, depending on the ratio of concentrations of both substances in the system, leads to a reduction in the number of soldiers, or the formation of soldiers is completely prevented. In many cases, transitional forms between soldiers and larvae, the so-called interkasta. Influence is reported in the form of a fraction, where the numerator shows the percentage of fully developed white soldiers, while the denominator indicates the percentage of interkasts formed.
2.2- dimetyl-3-borm-3,4-dihydro-4-metoxy-6-propionyl-2H-benzopyran (0,1 hmot. %) + metoprén (0,1 hmot. %): 0/0 po 9 dnech, 0/0 po 10 dnech, 13/0 po 13 dnech, 13/53 po 15 dnech, 13/53 po 19 dnech2.2-Dimethyl-3-bromo-3,4-dihydro-4-methoxy-6-propionyl-2H-benzopyran (0.1 wt%) + methoprene (0.1 wt%): 0/0 after 9 days 0/0 after 10 days, 13/0 after 13 days, 13/53 after 15 days, 13/53 after 19 days
2,2-dimetyl-3-metoxy-3,4-dihydro-4-brom-6-[dimetyl-(4-acetoxyfenyl)metyl]-2H-benzopyran (0,2 hmot. %): 0/0 po 12 dnech, 0/0 po 14 dnech, 0/0 po 16 dnech srovnání s účinky precocenu:2,2-dimethyl-3-methoxy-3,4-dihydro-4-bromo-6- [dimethyl- (4-acetoxyphenyl) methyl] -2H-benzopyran (0.2 wt%): 0/0 to 12 days, 0/0 after 14 days, 0/0 after 16 days comparison with precocene effects:
metoprén (0,1 hmot. %) + precocen (0,1 hmot. %): 7/3 po 13 dnech, 37/3 po 15 dnech,methoprene (0.1 wt%) + precocene (0.1 wt%): 7/3 after 13 days, 37/3 after 15 days,
43/7 po 17 dnech, 43/20 po 21 dnech, 43/20 po 33 dnech metoprén (0,1 hmot. %): 0/0 po 9 dnech, 40/0 po 12 dnech, 53/0 po 15 dnech, 53/0 po 17 dnech;43/7 after 17 days, 43/20 after 21 days, 43/20 after 33 days methoprene (0.1 wt%): 0/0 after 9 days, 40/0 after 12 days, 53/0 after 15 days 53/0 after 17 days;
Antífeedantní účinky:Antifeeding effects:
jako testovací organismus byl použit Coptotermes formosanum (aplikace na chromatografický papír Whatman č. 2 v acetonu). Pro 2,2-dimetyl-3-brom-3,4-dihydro-4-metoxy-6-propionyl-2H-benzopyran (0,001 hmot. %) v acetonu nastává u termitů snížení žravosti o 61 % oproti kontrolním skupinám termitů.Coptotermes formosanum was used as a test organism (application to Whatman No. 2 chromatography paper in acetone). For 2,2-dimethyl-3-bromo-3,4-dihydro-4-methoxy-6-propionyl-2H-benzopyran (0.001 wt.%) In acetone, termites reduce the glutenity by 61% compared to termite control groups.
Pro .2,2-dimetyl-3-metoxy-3,4-dihydro-4-brom-6-[dimety1-(4-acetoxyfenyl(metyl] -2H-benzopyran (0,001 hmot. %) o 62 %.For .2,2-dimethyl-3-methoxy-3,4-dihydro-4-bromo-6- [dimethyl- (4-acetoxyphenyl (methyl) -2H-benzopyran) (0.001 wt%) by 62%.
Pro 2,2-dimetyl-3-metoxy-3,4-dihydro-4-brom-6-[dimetyl-(4-hydroxyfenyl)metyl[]-2H-benzopyran (0,01 hmot. %) o 60For 2,2-dimethyl-3-methoxy-3,4-dihydro-4-bromo-6- [dimethyl- (4-hydroxyphenyl) methyl [] - 2H-benzopyran (0.01 wt%) of 60
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS862875A CS252629B1 (en) | 1983-09-01 | 1986-04-21 | Biologically active halogen-containing 2H-benzopyran derivatives per molecule and method for their preparation |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS836297A CS252601B1 (en) | 1983-09-01 | 1983-09-01 | 2h-benzopyran's biologically efficient derivatives and method of their preparation |
| CS862875A CS252629B1 (en) | 1983-09-01 | 1986-04-21 | Biologically active halogen-containing 2H-benzopyran derivatives per molecule and method for their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS252629B1 true CS252629B1 (en) | 1987-09-17 |
Family
ID=5409684
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS836297A CS252601B1 (en) | 1983-09-01 | 1983-09-01 | 2h-benzopyran's biologically efficient derivatives and method of their preparation |
| CS8410339A CS260904B1 (en) | 1983-09-01 | 1984-12-27 | Ester-linked 2H-benzopyran derivatives as a biologically active substance and a process for their preparation |
| CS862875A CS252629B1 (en) | 1983-09-01 | 1986-04-21 | Biologically active halogen-containing 2H-benzopyran derivatives per molecule and method for their preparation |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS836297A CS252601B1 (en) | 1983-09-01 | 1983-09-01 | 2h-benzopyran's biologically efficient derivatives and method of their preparation |
| CS8410339A CS260904B1 (en) | 1983-09-01 | 1984-12-27 | Ester-linked 2H-benzopyran derivatives as a biologically active substance and a process for their preparation |
Country Status (1)
| Country | Link |
|---|---|
| CS (3) | CS252601B1 (en) |
-
1983
- 1983-09-01 CS CS836297A patent/CS252601B1/en unknown
-
1984
- 1984-12-27 CS CS8410339A patent/CS260904B1/en unknown
-
1986
- 1986-04-21 CS CS862875A patent/CS252629B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS252601B1 (en) | 1987-09-17 |
| CS629783A1 (en) | 1987-02-12 |
| CS1033984A1 (en) | 1988-05-16 |
| CS260904B1 (en) | 1989-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU884567A3 (en) | Method of preparing cyclohexane derivatives of their salts | |
| FR2598146B1 (en) | NEW PROCESS FOR THE PREPARATION OF FIBRATES. | |
| ES483767A1 (en) | PROCEDURE FOR PRODUCING N-ARYLSULFONYL-L-ARGININAMIDES | |
| DE3883330D1 (en) | AMINOARYL SULPHONIC ACID PHENOL FORMALDEHYDE CONDENSATE AND CEMENT MIXTURE THAT CONTAINS THIS. | |
| DE3174293D1 (en) | Derivatives of aldohexoses, intermediates, process for their production, preparations containing such compositions and their use | |
| KR890008156A (en) | Novel alcoholic derivatives of gingkolide, preparation method thereof and therapeutic composition containing the same | |
| KR830010039A (en) | Method for preparing phenyl fatty carboxylic acid derivative | |
| CS252629B1 (en) | Biologically active halogen-containing 2H-benzopyran derivatives per molecule and method for their preparation | |
| ES2015068B3 (en) | NEW SUBSTITUTED DERIVATIVES OF N-ETIL (MET) ACRYLAMINE AND PROCEDURE FOR ITS PREPARATION. | |
| EP0269514A3 (en) | Derivatives of 2,2-dimethylcyclopropanecarboxylic acid bearing a saturated halogenated chain at c-3, process and intermediates for their preparation, their use as pesticides and compositions containing them | |
| ES2054675T3 (en) | A PROCEDURE FOR THE PREPARATION OF ISOTIAZOLONES. | |
| CS261251B1 (en) | Alkyl-4- (alkoxyalkoxy) phenyl ketones with halogen in the alkoxy group and a process for their preparation | |
| IE821315L (en) | PREPARATION OF 5,6,7,7a-TETRAHYDRO-4H-THIENO-£3,2-c|¹PYRIDIN-2-ONES | |
| JPS55100356A (en) | Benzenediol derivative | |
| US3884962A (en) | Phenylcarbamates | |
| GB777718A (en) | New organic compounds containing phosphorus and process for making them | |
| JPS5463024A (en) | 3-(n-formyl-n-hydroxyamino)-2(r)-hydroxypropyl-phosphonic acid, its preparation, and its use | |
| JPS56113733A (en) | 3-substituted-3-fluoropyruvic acid, its ester, salt and preparation thereof | |
| ES502947A0 (en) | PROCEDURE FOR THE OBTAINING OF ESTERS OF DIMETH ACID-CRYLIC | |
| RU2005716C1 (en) | Pentafluorobenzyl 1r,3s-2,2-dimethyl-3-(2-chlorophenyl) cyclopropancarboxylate | |
| DE3317159C2 (en) | ||
| PT80993B (en) | A process for the preparation of 1- (aminophenyl) -2-amino-ethanone derivatives | |
| IE33067B1 (en) | 3-amino-7-(pyrrolylcarbonyl)noviosyloxy-coumarin derivatives and pharmaceutical composition containing them | |
| KR860000262A (en) | Method for preparing 3-nitro-dihydro pyridine | |
| SU150792A1 (en) | Method for producing alkocemethylenamides of 0,0-dialkylthio and 0,0-dialkyl dithiophosphoryl acetic acid |